Preclinical evaluation of dasatinib alone and in combination with cabozantinib for the treatment of diffuse intrinsic pontine glioma.

MLA

Truffaux, Nathalène, et al. “Preclinical Evaluation of Dasatinib Alone and in Combination with Cabozantinib for the Treatment of Diffuse Intrinsic Pontine Glioma.” Neuro-Oncology, vol. 17, no. 7, July 2015, pp. 953–64. EBSCOhost, https://doi.org/10.1093/neuonc/nou330.

APA

Truffaux, N., Philippe, C., Paulsson, J., Andreiuolo, F., Guerrini-Rousseau, L., Cornilleau, G., Le Dret, L., Richon, C., Lacroix, L., Puget, S., Geoerger, B., Vassal, G., Östman, A., & Grill, J. (2015). Preclinical evaluation of dasatinib alone and in combination with cabozantinib for the treatment of diffuse intrinsic pontine glioma. Neuro-Oncology, 17(7), 953–964. https://doi.org/10.1093/neuonc/nou330

Chicago

Truffaux, Nathalène, Cathy Philippe, Janna Paulsson, Felipe Andreiuolo, Léa Guerrini-Rousseau, Gaétan Cornilleau, Ludivine Le Dret, et al. 2015. “Preclinical Evaluation of Dasatinib Alone and in Combination with Cabozantinib for the Treatment of Diffuse Intrinsic Pontine Glioma.” Neuro-Oncology 17 (7): 953–64. doi:10.1093/neuonc/nou330.